CoChat

Does the Duration of Index Episode Affect the Treatment Outcome of Major Depressive Disorder?: A STAR*D Report

Gilmer, William S., Gollan, Jackie K., Wisniewski, Stephen R., Howland, Robert H., Trivedi, Madhukar H., Miyahara, Sachiko, Fleck, Janelle, Thase, Michael E., Alpert, Jonathan E., Nierenberg, Andrew A., Warden, Diane, Fava, Maurizio, Rush, A. John · 2008 · The Journal of Clinical Psychiatry
Cited by 46

The DOI matches its Crossref record.

Abstract

Article Abstract Objective: This article aims to identify baseline sociodemographic and clinical characteristics associated with the duration of the index major depressive episode (MDE) and to assess the effect of the current MDE duration on response and remission rates with up to 14 weeks of citalopram. Method: Eligible participants met DSM-IV criteria for nonpsychotic major depressive disorder, scored >= 14 on the 17-item Hamilton Rating Scale for Depression (HAM-D-17), and were not resistant to adequate antidepressant treatment in the current episode. The first patient was enrolled in July 2001 and the last visit for the last patient in follow-up was in March 2006. The evaluable sample (N = 2851) was divided into 4 groups based on the index MDE duration at study entry: acute (= 42 months, N = 394). These 4 groups were compared in terms of baseline sociodemographic and clinical characteristics and treatment outcomes. Citalopram was generally begun at 20 mg/day and raised to 40 mg/day by weeks 2 through 4 and to 60 mg/day (final dose) by weeks 4 through 6. Logistic regression models with adjusted post hoc analyses were used to control for associated baseline characteristics. Response was defined as >= 50% reduction in baseline 16-item Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR-16) scores at exit. Remission was defined as <= 7 on the HAM-D-17 or <= 5 on the QIDS-SR-16. Results: MDE duration was longer in primary care settings, blacks, Hispanics, single or widowed, unemployed, publicly insured or uninsured, older, and less educated participants and in those with lower income, less recurrence, or greater concurrent general medical or Axis I comorbidities. HAM-D-17 remission rates ranged from 31.0% (acute group) to 24.1% (ultrachronic group). HAM-D-17 remission rates were significantly related to MDE duration (p = .0010), but after adjustments for baseline differences among the 4 groups, remission rates were not different. QIDS-SR-16 response rates were lower for the subacute and chronic groups but not different for the acute and ultrachronic groups after adjustment. Conclusion: Longer MDE duration is associated with socioeconomic disadvantage and greater Axis I and medical comorbidity. Episode duration per se does not significantly affect the likelihood of remission. Trial Registration: clinicaltrials.gov Identifier: NCT00021528

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4088/jcp.v69n0807

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 46

Metadata

Authors
Gilmer, W. S., Gollan, J. K., Wisniewski, S. R., Howland, R. H., Trivedi, M. H., Miyahara, S., Fleck, J., Thase, M. E., Alpert, J. E., Nierenberg, A. A., Warden, D., Fava, M., & Rush, A. J.
Venue
The Journal of Clinical Psychiatry
Published
2008-08-15
Volume
69
Issue
8
Pages
1246-1256
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2081553996
Cited by
46
References
0
FWCI
2.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Does the Duration of Index Episode Affect the Treatment Outcome of Major Depressive Disorder?: A STAR*D Report. https://app.cochat.ai/papers/10.4088/jcp.v69n0807
The paper
Gilmer, W. S., Gollan, J. K., Wisniewski, S. R., Howland, R. H., Trivedi, M. H., Miyahara, S., Fleck, J., Thase, M. E., Alpert, J. E., Nierenberg, A. A., Warden, D., Fava, M., & Rush, A. J. (2008). Does the Duration of Index Episode Affect the Treatment Outcome of Major Depressive Disorder?: A STAR*D Report. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v69n0807

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.